Skip to Main Content

Paper Details

Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
Elife
117
2018
-SSX fusion, BAF complexes, BRD9, SS18, SSX, Synovial, Synovial sarcoma tumours, oncogenic, oncogenic gene, sarcoma, synovial sarcoma, synovial sarcoma cells, synovial sarcoma genome, tumour
Author NameAffiliation
Kieran WynneSchool of Biomolecular and Biomedical Science and Conway Institute, University College Dublin
Eugene T DillonSchool of Biomolecular and Biomedical Science and Conway Institute, University College Dublin
Gerard CagneySchool of Biomolecular and Biomedical Science and Conway Institute, University College Dublin
Jun QiDana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School
Stefan Fr??hling
Stefan Fr??hlingHeidelberg University Hospital
Stefan Fr??hlingNational Center for Tumor Diseases Heidelberg and German Cancer Research Center
Nathanael S GrayDana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School
Nathanael S GrayDana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School
James E BradnerDana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School
Scott A ArmstrongDana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School
Scott A ArmstrongDana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School
  • 1 - 12

Datasets